Persistence of Cardiovascular Risk After Rofecoxib Discontinuation

Archives of Internal Medicine
doi 10.1001/archinternmed.2010.461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Persistence of Macrocytosis After Discontinuation of Zidovudine in HIV-Infected Patients

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2017English

Persistence of Sexual Dysfunction Side Effects After Discontinuation of Antidepressant Medications: Emerging Evidence

Open Psychology Journal
Psychology
2008English

Celecoxib Carries Lower Risk of Upper GI Haemorrhage Than Rofecoxib

BMJ
2002English

Clinical Risk Factors and Outcomes of Massive Ascites Accumulation After Discontinuation of Peritoneal Dialysis

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2019English

Is There an Increased Risk of Twinning After Discontinuation of the Oral Contraceptive Pill?

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
1989English

Incidence of Cardiovascular Events After Kidney Transplantation and Cardiovascular Risk Scores: Study Protocol

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2011English

Underestimation of Vertebral Fractures After Denosumab Discontinuation

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Does Half-Life Matter After Antipsychotic Discontinuation?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2017English

Cardiovascular Risk After Hospitalisation for Unexplained Syncope and Orthostatic Hypotension

Heart
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy